Related Experiment Video
Updated: Aug 21, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
[Multiple sclerosis and anti-phospholipid syndrome--one or two diseases?]
Anat Achiron1, Mathilda Mandel, Yehuda Shoenfeld
1The Center for Multiple Sclerosis, Sheba Medical Center, Tel-Hashomer. achiron@post.tau.ac.il
Abstract:
Multiple sclerosis is an autoimmune central nervous system disease that affects young adults and causes inflammation, demyelination and axonal loss. Within the common relapsing-remitting course of the disease patients develop various neurological symptoms that lead to significant disability overtime. The anti-phospholipid syndrome, similarly to multiple sclerosis, appears in young adults and is characterized by thromboembolic events and pregnancy complications. The overlay between these two diseases and the ability to correctly diagnose or differentiate between them is sometimes difficult. The current review approaches this problem and discusses whether multiple sclerosis and anti-phospholipid syndrome are actually one or two diseases.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

